A chemical industry has to be good at blending and mixing, so it should come as no surprise that you also do so with the companies themselves. The new CPhI Annual Report1 suggests that we will see more large API-led firms trying to merge or partner with finished product specialists, and many of the largest players are looking holistically at how they can meet future challenges – with more mega-mergers likely to be attempted. With the stage set for exciting times, here is Speciality Chemicals Magazine’s round-up of some of the important deals that have been going on over the past couple of weeks.
The Nobel Prize in Chemistry 2016 went to three scientists who helped create the world’s smallest machines: a miniscule lift, artificial muscles and tiny motors. Jean-Pierre Sauvage, Sir J Fraser Stoddart and Bernard L Feringa are now Nobel laureates for their development of molecules with movements that can be controlled.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the American Society for Microbiology (ASM) held a joint conference in Vienna last week, aimed at helping researchers accelerate the development of new antimicrobials, and shedding light on the challenges associated with antimicrobial resistance.
CPhI Worldwide announced the winners of the distinguished 2016 CPhI Pharma Awards live at a dedicated gala dinner Barcelona on October 5th. The awards honour companies and individuals driving the pharma industry forward through innovations, new approaches, technologies and strategies.
Dow Corning, a global leader in silicones, silicon-based technology and innovation, introduced two new, cutting-edge solutions at CPhI Worldwide 2016 in Barcelona, earlier this month. The company exhibited a kit of sample formulations for acne management featuring Dow Corning brand Topical Ingredients, and three new silicone blends for skin barrier applications and adhesive and film removal.
STK Stockton has opened new US headquarters in Davis, California, in preparation for the US commercialization of Timorex Gold, a natural fungicide that may be used on a range of crops. The product recently received US registration from the Environmental Protection Agency (EPA), and has since obtained approval in a number of states. Now expecting imminent approval in the key states of Florida and California, this is an opportune time for Stockton to fully enter the US market.
September 13th marked the official opening of a new Development Centre at Aesica Pharmaceuticals’ Queenborough site on the South-East coast of the UK. The effort effectively doubles this global CDMO’s development capacity, and allows Aesica to develop and manufacture a drug product, from early formulation development through to a packaged finished product, all on one campus. Sarah Harding, Editor of Speciality Chemicals Magazine, was there to see how this one-site offering is intended to provide a seamless end-to-end service for the customer.
Published: October 17, 2016
October 12th saw the International Fragrance Association’s (IFRA) UK’s symposium in London. This year, IFRA UK invited a group of distinguished presenters to consider the effects of aroma on our development, health, and history.